News Releases

All Releases
View Summary FDA Approves New Styles Of The MENTOR® MemoryShape® Silicone Breast Implant
Sep 15, 2014
PDF 14.6 KB Add to Briefcase
View Summary Cordis Corporation Launches INCRAFT® AAA Stent Graft System for Treatment of Abdominal Aortic Aneurysms (AAA)
Sep 10, 2014
PDF 12.8 KB Add to Briefcase
View Summary Johnson & Johnson Responds to Ebola Crisis With Commitment to Accelerate Vaccine Program in Collaboration With the US National Institutes of Health (NIH) and Provide Humanitarian Relief Aid
Sep 4, 2014
PDF 13.7 KB Add to Briefcase
View Summary Johnson & Johnson to Participate in 2014 Morgan Stanley Health Care Conference
Sep 3, 2014
PDF 5.7 KB Add to Briefcase
View Summary New Data Show Once-Daily XARELTO® May Be an Alternative to Vitamin K Antagonists in Treating Atrial Fibrillation Patients Undergoing Elective Cardioversion
Sep 2, 2014
PDF 32.2 KB Add to Briefcase
View Summary Janssen Expands EXPLORER Global Cardiovascular Research Program to Evaluate the Role of XARELTO® in Addressing Critical Medical Needs
Aug 29, 2014
PDF 24.2 KB Add to Briefcase
View Summary Janssen Affiliate Cilag GmbH International Acquires Covagen AG
Aug 25, 2014
PDF 11.5 KB Add to Briefcase
View Summary U.S. FDA Approves INVOKAMET® (canagliflozin/metformin HCl) for the Treatment of Adults with Type 2 Diabetes
Aug 8, 2014
PDF 27.0 KB Add to Briefcase
View Summary Phase 2 COSMOS Study Results Published in The Lancet Demonstrate Efficacy and Safety of Janssen's Once-Daily Simeprevir in All Oral 12-Week Combination with Sofosbuvir for Genotype 1 Chronic Hepatitis C
Jul 28, 2014
PDF 20.3 KB Add to Briefcase
  IMBRUVICA® (ibrutinib) Receives Regular Approval by U.S. FDA in Chronic Lymphocytic Leukemia (CLL) and CLL patients with del 17p
Jul 28, 2014
PDF 106.3 KB Add to Briefcase
View Summary Ethicon Launches HARMONIC FOCUS®+ Shears With Adaptive Tissue Technology At IFHNOS/AHNS Scientific Meeting
Jul 28, 2014
PDF 15.9 KB Add to Briefcase
View Summary Janssen Receives Positive CHMP Opinion Recommending IMBRUVICA for use in the Treatment of Two Forms of Blood Cancer
Jul 25, 2014
 
View Summary Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2014
Jul 21, 2014
PDF 5.6 KB Add to Briefcase
View Summary Johnson & Johnson Announces $5 Billion Share Repurchase Program
Jul 21, 2014
PDF 7.6 KB Add to Briefcase
View Summary Johnson & Johnson Reports 2014 Second-Quarter Results:
Jul 15, 2014
PDF 64.5 KB Add to Briefcase
View Summary Janssen Pharmaceuticals Seeks Expanded Label for Once-Monthly INVEGA® SUSTENNA® (paliperidone palmitate) to Show Delayed Time to Relapse Compared to Daily Oral Schizophrenia Therapies
Jul 14, 2014
PDF 70.0 KB Add to Briefcase
View Summary CEO and Chairman of UPS, D. Scott Davis, Joins Johnson & Johnson Board of Directors
Jul 7, 2014
PDF 6.7 KB Add to Briefcase
View Summary Cordis Corporation Launches SABER PTA Dilatation Catheter to Complement Portfolio of Peripheral Arterial Disease Treatments
Jul 1, 2014
PDF 9.8 KB Add to Briefcase
View Summary Johnson & Johnson Completes Divestiture Of Ortho-Clinical Diagnostics To The Carlyle Group
Jun 30, 2014
PDF 6.8 KB Add to Briefcase
View Summary Janssen Submits Eu Marketing Application For Velcade® (Bortezomib) In Mantle Cell Lymphoma
Jun 27, 2014
PDF 63.2 KB Add to Briefcase

= add release to Briefcase